Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
Michael Campoli, Soldano Ferrone
Seminars in Immunopathology (2011) Vol. 33, Iss. 4, pp. 321-334
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 191
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
Marie Kostine, Arjen H.G. Cleven, Noel F.C.C. de Miranda, et al.
Modern Pathology (2016) Vol. 29, Iss. 9, pp. 1028-1037
Open Access | Times Cited: 101
Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults
Shlomit Radom‐Aizik, Frank Zaldivar, Fadia Haddad, et al.
Journal of Applied Physiology (2013) Vol. 114, Iss. 5, pp. 628-636
Open Access | Times Cited: 96
“In vitro” 3D models of tumor-immune system interaction
Christian Hirt, Adam Papadimitropoulos, Valentina Mele, et al.
Advanced Drug Delivery Reviews (2014) Vol. 79-80, pp. 145-154
Closed Access | Times Cited: 84
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
Barbara Seliger, Matthias Kloor, Soldano Ferrone
OncoImmunology (2017) Vol. 6, Iss. 2, pp. e1171447-e1171447
Open Access | Times Cited: 83
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
Josefa Antonia Rodrı́guez
Oncology Letters (2017) Vol. 14, Iss. 4, pp. 4415-4427
Open Access | Times Cited: 79
Personalized cancer vaccines: Targeting the cancer mutanome
Xiuli Zhang, Piyush Kumar Sharma, S. Peter Goedegebuure, et al.
Vaccine (2016) Vol. 35, Iss. 7, pp. 1094-1100
Open Access | Times Cited: 65
Molecular mechanisms of HLA class I‐mediated immune evasion of human tumors and their role in resistance to immunotherapies
Barbara Seliger
HLA (2016) Vol. 88, Iss. 5, pp. 213-220
Closed Access | Times Cited: 50
Alteration of HLA‐F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma
X. Zhang, Aifen Lin, J.‐G. Zhang, et al.
International Journal of Cancer (2012) Vol. 132, Iss. 1, pp. 82-89
Closed Access | Times Cited: 51
Contagious cancer: Lessons from the devil and the dog
Katherine Belov
BioEssays (2012) Vol. 34, Iss. 4, pp. 285-292
Closed Access | Times Cited: 47
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Raquel Tarazona, Esther Durán, Rafael Solana
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 47
HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin, Xia Zhang, Huihui Xu, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 1, pp. 150-157
Closed Access | Times Cited: 41
The Prognostic Role of CD8+ T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score
Ivy Z.S. Parise, Guilherme A. Parise, Lúcia de Noronha, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1730-1730
Open Access | Times Cited: 31
Association of KIR gene polymorphisms with COVID-19 disease
Ali H. Hajeer, Dunia Jawdat, Salam Massadeh, et al.
Clinical Immunology (2021) Vol. 234, pp. 108911-108911
Open Access | Times Cited: 24
NK cytolysis is dependent on the proportion of HLA-G expression
Baoguo Chen, Dan‐Ping Xu, Aifen Lin, et al.
Human Immunology (2012) Vol. 74, Iss. 3, pp. 286-289
Closed Access | Times Cited: 38
Low expression of HLA‐DRA, HLA‐DPA1, and HLA‐DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT)
Fabíola A. Leite, Régia Caroline Peixoto Lira, Paola Fernanda Fedatto, et al.
Pediatric Blood & Cancer (2014) Vol. 61, Iss. 11, pp. 1940-1948
Closed Access | Times Cited: 33
Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model
Shintaro Ishikawa, Takako Ishikawa, Chiaki Tezuka, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 30
Cancer treatment and the KIR–HLA system: an overview
Patrizia Leone, Vallì De Re, Angelo Vacca, et al.
Clinical and Experimental Medicine (2017) Vol. 17, Iss. 4, pp. 419-429
Closed Access | Times Cited: 29
Distribution of several activating and inhibitory receptors on CD3−CD56+ NK cells in regional lymph nodes of melanoma patients
Ana Vuletić, Vladimir Jurišić, Irena Jovanić, et al.
Journal of Surgical Research (2013) Vol. 183, Iss. 2, pp. 860-868
Closed Access | Times Cited: 28
Peripheral blood cells inform on the presence of breast cancer: A population‐based case–control study
Vanessa Dumeaux, Josie Ursini‐Siegel, Arnar Flatberg, et al.
International Journal of Cancer (2014) Vol. 136, Iss. 3, pp. 656-667
Open Access | Times Cited: 26
In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15
Ana Vuletić, Irena Jovanić, Vladimir Jurišić, et al.
Melanoma Research (2014) Vol. 25, Iss. 1, pp. 22-34
Closed Access | Times Cited: 26
Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines
Lijin Li, Peter S. Goedegebuure, Elaine R. Mardis, et al.
Cancers (2011) Vol. 3, Iss. 4, pp. 4191-4211
Open Access | Times Cited: 26
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 2
Immunotherapy as a Potential Treatment for Chordoma: a Review
Shalin S. Patel, Joseph H. Schwab
Current Oncology Reports (2016) Vol. 18, Iss. 9
Closed Access | Times Cited: 19
New avenues for melanoma immunotherapy: Natural Killer cells?
Costanza Maria Cristiani, Cinzia Garofalo, Lucia Carmela Passacatini, et al.
Scandinavian Journal of Immunology (2019) Vol. 91, Iss. 4
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top